FEATURED LISTINGS

Tech-2503: Very Profitable, Well-Established Clinical Lab in the South East

The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. Projected 2021 Revenue: $6M, EBITDA: $2M.

Read more Contact us

Tech–20090: Manufacturer of Flow Rate Calibration Equipment offering Great Growth Opportunity

The Company is specialized in the design, assembly, service, programming and certification of flow rate calibration equipment. Revenue: $1.87M; EBITDA: $650K (proj. for next 12 months).

Read more Contact us

Tech-Real-6090: Laboratory Space in Central NJ (Currently a Tox Lab)

4.000 sq. ft of lab space available for lease as of Dec 1, 2020. Currently running as a clinical lab doing toxicology and other clinical testing.

Read more Contact us

Tech–2495: Well-Established, Very Profitable Structural Testing Laboratory in California

The Lab has very stable revenues, is consistently profitable with high EBITDA margins and offers a high growth opportunity. Revenue: $1.21M; EBITDA: $608K; asking price: $2.25M.

Read more Contact us

Tech-Real-6089: Auction March 18, 2021 – Fully Equipped Chemistry Research Lab in Cleveland, OH

12,500 sq. ft. Research Lab with Wet-Lab capability, formerly occupied by Sherwin Williams R&D group. Immediately available. Many first-class amenities. Two Acre property. Auction Reserve Price: $375K; Original Price: $795,000.

Read more Contact us

Tech-2469: New Tox Lab in NC – Can be Ready for Covid Testing in 4-8 weeks

New Toxicology lab in NC. With Medicare and NC Medicaid, high complexity CLIA. Can be Covid-Testing ready in 4-8 weeks. Asking Price $375K.

Read more Contact us

ALL CURRENT LISTINGS

These are our current listings.

Besides our Featured listings below, see all our current listings by following links below:

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

[contact-form-7 id='5594' title='Untitled' ]